Recipient APOL1 risk alleles associate with death-censored renal allograft survival and rejection episodes

Zhongyang Zhang(Icahn School of Medicine at Mount Sinai), Madhav C. Menon(Yale University), Qisheng Lin(Icahn School of Medicine at Mount Sinai), Zeguo Sun(Icahn School of Medicine at Mount Sinai), Barbara Murphy, Robert B. Colvin(Harvard University), Philip J. O’Connell(The University of Sydney), John Cijiang He(James J. Peters VA Medical Center), Ian W. Gibson(University of Manitoba), Jia Fu(Harbin Medical University), Kinsuk Chauhan(Icahn School of Medicine at Mount Sinai), Haoxiang Cheng(Icahn School of Medicine at Mount Sinai), Zhengzi Yi(Icahn School of Medicine at Mount Sinai), Steven G. Coca(Icahn School of Medicine at Mount Sinai), Fadi Salem(Icahn School of Medicine at Mount Sinai), Shuta Ishibe(Yale University), Peter S. Heeger(Cedars-Sinai Medical Center), Khadija Banu(Yale University), Weijia Zhang(Shandong University), Ruijie Liu(University of Chinese Academy of Sciences), Marina Planoutene(Icahn School of Medicine at Mount Sinai), Chengguo Wei(Icahn School of Medicine at Mount Sinai), Ke Hao(Boston University)
medRxiv
May 8, 2021
Cited by 11


Related Papers